Inhibition of Tumour Growth by Lipoxygenase Inhibitors
Author Information
Author(s): HJ Hussey, MJ Tisdale
Primary Institution: Pharmaceutical Sciences Institute, Aston University
Hypothesis
The study investigates the role of lipoxygenase metabolites in the growth of tumours stimulated by arachidonic and linoleic acid.
Conclusion
The study found that lipoxygenase inhibitors can effectively inhibit the growth of certain murine adenocarcinomas.
Supporting Evidence
- BWA4C and BWB70C were effective inhibitors of murine adenocarcinoma growth.
- Zileuton was less effective compared to BWA4C and BWB70C.
- IC50 values for BWA4C and BWB70C were less than 10 µM.
- BWA4C significantly reduced MAC26 tumour volume at doses of 5 to 25 mg/kg.
- Lower doses of BWB70C were ineffective or stimulated tumour growth.
Takeaway
Some medicines can help stop cancer from growing by blocking certain fats in the body.
Methodology
The study used in vitro and in vivo experiments with murine adenocarcinoma cell lines and lipoxygenase inhibitors.
Limitations
The study primarily focused on murine models, which may not fully represent human cancer biology.
Participant Demographics
Male NMRI mice, average body weight 25-30 g, age 6 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website